261 related articles for article (PubMed ID: 28860343)
41. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
[TBL] [Abstract][Full Text] [Related]
42. Migration of acute lymphoblastic leukemia cells into human bone marrow stroma.
Makrynikola V; Bianchi A; Bradstock K; Gottlieb D; Hewson J
Leukemia; 1994 Oct; 8(10):1734-43. PubMed ID: 7523799
[TBL] [Abstract][Full Text] [Related]
43. Detection and role of minimal disseminated disease in children with lymphoblastic lymphoma: The AIEOP experience.
Mussolin L; Buldini B; Lovisa F; Carraro E; Disarò S; Lo Nigro L; d'Amore ES; Pillon M; Basso G
Pediatr Blood Cancer; 2015 Nov; 62(11):1906-13. PubMed ID: 26109265
[TBL] [Abstract][Full Text] [Related]
44. Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.
van der Velden VH; Szczepanski T; Wijkhuijs JM; Hart PG; Hoogeveen PG; Hop WC; van Wering ER; van Dongen JJ
Leukemia; 2003 Sep; 17(9):1834-44. PubMed ID: 12970784
[TBL] [Abstract][Full Text] [Related]
45. [Analysis of heavy chain immunoglobulins gene and T-cell receptor delta gene in children with acute leukemia].
Pan Q; Chou Y; Hong W
Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):529-31, 573. PubMed ID: 8556542
[TBL] [Abstract][Full Text] [Related]
46. Early resistance to therapy during induction in childhood acute lymphoblastic leukemia.
Brisco MJ; Sykes PJ; Dolman G; Hughes E; Neoh SH; Peng L; Snell LE; Toogood IR; Rice MS; Morley AA
Cancer Res; 2000 Sep; 60(18):5092-6. PubMed ID: 11016634
[TBL] [Abstract][Full Text] [Related]
47. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
Seriu T; Yokota S; Nakao M; Misawa S; Takaue Y; Koizumi S; Kawai S; Fujimoto T
Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394
[TBL] [Abstract][Full Text] [Related]
48. Mutational profiling of acute lymphoblastic leukemia with testicular relapse.
Ding LW; Sun QY; Mayakonda A; Tan KT; Chien W; Lin DC; Jiang YY; Xu L; Garg M; Lao ZT; Lill M; Yang H; Yeoh AE; Koeffler HP
J Hematol Oncol; 2017 Mar; 10(1):65. PubMed ID: 28253933
[TBL] [Abstract][Full Text] [Related]
49. High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias.
Hübner S; Cazzaniga G; Flohr T; van der Velden VH; Konrad M; Pötschger U; Basso G; Schrappe M; van Dongen JJ; Bartram CR; Biondi A; Panzer-Grümayer ER
Leukemia; 2004 Jan; 18(1):84-91. PubMed ID: 14574333
[TBL] [Abstract][Full Text] [Related]
50. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A
Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294
[TBL] [Abstract][Full Text] [Related]
51. [Identification of immunoglobulin and T-cell receptor gene rearrangements--prerequisite for monitoring of minimal residual disease in Polish acute lymphoblastic leukemia patients based on European standards. Preliminary results].
Dawidowska M; Derwich K; Szczepański T; Jółkowska J; Witt M; Wachowiak J
Med Wieku Rozwoj; 2006; 10(1 Pt 2):323-34. PubMed ID: 17028396
[TBL] [Abstract][Full Text] [Related]
52. Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications.
Darzentas F; Szczepanowski M; Kotrová M; Hartmann A; Beder T; Gökbuget N; Schwartz S; Bastian L; Baldus CD; Pál K; Darzentas N; Brüggemann M
Front Immunol; 2023; 14():1125017. PubMed ID: 37143651
[TBL] [Abstract][Full Text] [Related]
53. Molecular analysis of single colonies reveals a diverse origin of initial clonal proliferation in B-precursor acute lymphoblastic leukemia that can precede the t(12;21) translocation.
Weston VJ; McConville CM; Mann JR; Darbyshire PJ; Lawson S; Gordon J; Moss PA; Taylor AM; Stankovic T
Cancer Res; 2001 Dec; 61(23):8547-53. PubMed ID: 11731441
[TBL] [Abstract][Full Text] [Related]
54. Correctly recognizing leukemic cells in bone marrow in infants: importance of good training in hematological morphology.
Anand M; Kumar R; Ghara N; Thavaraj V
Indian J Pathol Microbiol; 2005 Jul; 48(3):420-1. PubMed ID: 16761778
[No Abstract] [Full Text] [Related]
55. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
[TBL] [Abstract][Full Text] [Related]
56. Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR.
van der Velden VH; Willemse MJ; van der Schoot CE; Hählen K; van Wering ER; van Dongen JJ
Leukemia; 2002 May; 16(5):928-36. PubMed ID: 11986956
[TBL] [Abstract][Full Text] [Related]
57. Identification of an altered immunoglobulin heavy-chain gene rearrangement in the central nervous system in B-precursor acute lymphoblastic leukemia.
Wasserman R; Felix CA; McKenzie SE; Shane S; Lange B; Finger LR
Leukemia; 1993 Aug; 7(8):1294-9. PubMed ID: 8350631
[TBL] [Abstract][Full Text] [Related]
58. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
[TBL] [Abstract][Full Text] [Related]
59. Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia.
Wright JJ; Poplack DG; Bakhshi A; Reaman G; Cole D; Jensen JP; Korsmeyer SJ
J Clin Oncol; 1987 May; 5(5):735-41. PubMed ID: 3494818
[TBL] [Abstract][Full Text] [Related]
60. Immunoglobulin light chain gene rearrangements display hierarchy in absence of selection for functionality in precursor-B-ALL.
van der Burg M; Barendregt BH; Szczepañski T; van Wering ER; Langerak AW; van Dongen JJ
Leukemia; 2002 Aug; 16(8):1448-53. PubMed ID: 12145684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
